|1.||Wounds and Injuries (Trauma)
|3.||Venous Thrombosis (Deep-Vein Thrombosis)
|1.||Sulikowski, T: 3 articles (10/2011 - 11/2007)|
|2.||Ostrowski, M: 3 articles (10/2011 - 11/2007)|
|3.||Rość, D: 3 articles (10/2011 - 11/2007)|
|4.||Nowacki, M: 2 articles (10/2011 - 10/2009)|
|5.||Sieńko, J: 2 articles (10/2011 - 11/2007)|
|6.||Zukowski, M: 2 articles (10/2011 - 10/2009)|
|7.||Zietek, Z: 2 articles (10/2009 - 11/2007)|
|8.||Iwan-Zietek, I: 2 articles (10/2009 - 11/2007)|
|9.||Alconero-Camarero, Ana Rosa: 1 article (07/2015)|
|10.||Fresno-García, Carmen: 1 article (07/2015)|
10/01/2009 - "The clinical symptoms included a decrease in 24-hour urine collection, an increase in plasma creatinine concentration, abdominal discomfort, lymphorrhea with a surgical wound dehiscence, voiding problems of urgency or vesical tenesmus, febrile states, or symptoms of deep vein thrombosis. "
11/01/2007 - "The clinical symptoms included the following: decreased 24-hour urine collection and increased creatinine level, abdominal discomfort, lymphorrhoea with surgical wound dehiscence, urgency, vesical tenesmus, and/or fever. "
10/01/2011 - "At 7 years follow-up 27 (11%) recipients had developed symptomatic lymphoceles, namely abdominal discomfort, a palpable mess in the lower abdomen, arterial hypertension, infection of the operative site with fever, lymphorrhoea with surgical wound dehiscence, decreased diurnal urine output with an elevated plasma creatinine, voiding problems of urgency and vesical tenesmus, and/or symptoms of deep vein thrombosis. "
|2.||Povidone-Iodine (Betadine)FDA LinkGeneric
|4.||Glucose (Dextrose)FDA LinkGeneric
02/01/2004 - "Surgical debridement and primary closure of superficial surgical wound dehiscence after median sternotomy is a safe and valid treatment. "
01/01/2011 - "Outcome variables included time of surgery, wound dehiscence, surgical site infection per Center for Disease Control criteria and repeat procedures for debridement and re-closure. "
03/01/2015 - "Among the defects, 10 were following trauma (50%), 5 were due to tumour resection (25%), 3 followed debridement of abscess (15%) and another 2 defects were due to surgical wound dehiscence (10%). "
|3.||Negative-Pressure Wound Therapy
07/01/2015 - "[Treatment of surgical wound dehiscence by topical negative pressure therapy: Clinical case]."
02/01/2005 - "Treating surgical wound dehiscence with negative pressure dressings."
07/01/2015 - "We report the case of a 75 year old man diagnosed with surgical wound dehiscence after a femorotibial bypass graft, who was hospitalized again with the aim to perform the implantation of a topical negative pressure therapy in the infected wound. "
|5.||Low-Level Laser Therapy (LLLT)